Harrow (HROW) News Today $43.64 +1.20 (+2.83%) (As of 02:50 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Former Harrow unit Melt announces results for MELT-300 to sedate for surgeryNovember 21 at 3:13 AM | markets.businessinsider.comFirst Turn Management LLC Makes New Investment in Harrow, Inc. (NASDAQ:HROW)First Turn Management LLC acquired a new position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm acquired 326,582 shares of the company's stock, valued at approximately $14,683,000. Harrow accounts for 2.November 19 at 6:08 AM | marketbeat.comOppenheimer & Co. Inc. Takes Position in Harrow, Inc. (NASDAQ:HROW)Oppenheimer & Co. Inc. bought a new stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The fund bought 28,177 shares of the company's stock, valued at approximately $1,267,000. Oppenheimer & Co. Inc. owned approximatNovember 19 at 3:58 AM | marketbeat.comHarrow Health’s Strategic Transformation and Growth Potential Underscore Buy RatingNovember 18 at 7:44 PM | markets.businessinsider.comHarrow (NASDAQ:HROW) Stock Price Down 7.3% - Time to Sell?November 17, 2024 | americanbankingnews.comHarrow, Inc. (NASDAQ:HROW) Stock Position Lessened by Royce & Associates LPRoyce & Associates LP decreased its holdings in Harrow, Inc. (NASDAQ:HROW - Free Report) by 33.3% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 360,320 shares of the company's stock after selling 179,580 shares during theNovember 16, 2024 | marketbeat.comHarrow: Spotlight On IHEEZONovember 16, 2024 | seekingalpha.comHarrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...November 15, 2024 | finance.yahoo.comHarrow (NASDAQ:HROW) Shares Down 7.3% - Here's WhyHarrow (NASDAQ:HROW) Shares Down 7.3% - What's Next?November 15, 2024 | marketbeat.comHarrow Inc. Reports Strong Q3 2024 GrowthNovember 15, 2024 | markets.businessinsider.comHarrow Health: Strong Growth Prospects Amid Market OverreactionNovember 15, 2024 | markets.businessinsider.comHarrow, Inc. (HROW) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comHarrow, Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 14, 2024 | seekingalpha.comHarrow (NASDAQ:HROW) Shares Gap Down - Here's WhyHarrow (NASDAQ:HROW) Shares Gap Down - Time to Sell?November 14, 2024 | marketbeat.comHarrow, Inc. (NASDAQ:HROW) Shares Sold by Los Angeles Capital Management LLCLos Angeles Capital Management LLC lowered its position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 47.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 43,109 shares of the company's stock after selling 38,168 sharesNovember 14, 2024 | marketbeat.comHarrow Health options imply 15.2% move in share price post-earningsNovember 13, 2024 | markets.businessinsider.comHarrow Launches Access and Affordability Program with Price Reductions for Branded ProductsNovember 13, 2024 | finance.yahoo.comHarrow stock plunges 20% on weaker-than-expected Q3 earningsNovember 13, 2024 | msn.comHarrow Announces Third Quarter 2024 Financial ResultsNovember 13, 2024 | businesswire.comEarnings Outlook For HarrowNovember 12, 2024 | benzinga.comHarrow Announces Market Access Wins for VEVYE®November 12, 2024 | finance.yahoo.comCraig-Hallum Sticks to Their Buy Rating for Harrow Health (HROW)November 11, 2024 | markets.businessinsider.comLake Street Releases a Buy Rating on Harrow Health (HROW)November 11, 2024 | markets.businessinsider.comHarrow: VEVYE And Its Impact On The DED MarketNovember 11, 2024 | seekingalpha.comHarrow (HROW) Set to Announce Earnings on WednesdayNovember 11, 2024 | americanbankingnews.comEquitable Trust Co. Lowers Position in Harrow, Inc. (NASDAQ:HROW)Equitable Trust Co. trimmed its position in Harrow, Inc. (NASDAQ:HROW - Free Report) by 30.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 58,225 shares of the company's stock after selling 25,275 sNovember 10, 2024 | marketbeat.comWoodmont Investment Counsel LLC Reduces Stock Position in Harrow, Inc. (NASDAQ:HROW)Woodmont Investment Counsel LLC trimmed its position in Harrow, Inc. (NASDAQ:HROW - Free Report) by 60.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 80,955 shares of the company's stock after selling 124,9November 7, 2024 | marketbeat.comHarrow (HROW) to Release Quarterly Earnings on WednesdayHarrow (NASDAQ:HROW) will be releasing earnings after the market closes on Wednesday, November 13, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=643038)November 6, 2024 | marketbeat.comRice Hall James & Associates LLC Purchases 59,019 Shares of Harrow, Inc. (NASDAQ:HROW)Rice Hall James & Associates LLC boosted its holdings in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 23.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 314,881 shares ofNovember 1, 2024 | marketbeat.comPositive Outlook for Harrow Health: Strategic Financial Management and Robust Revenue Growth Justify Buy RecommendationOctober 30, 2024 | markets.businessinsider.comSemanteon Capital Management LP Invests $686,000 in Harrow, Inc. (NASDAQ:HROW)Semanteon Capital Management LP bought a new position in Harrow, Inc. (NASDAQ:HROW - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 15,257 shares of the company's stock, valued at approximately $686,000.October 29, 2024 | marketbeat.comHarrow, Inc. (NASDAQ:HROW) Short Interest Down 14.5% in OctoberHarrow, Inc. (NASDAQ:HROW - Get Free Report) saw a significant drop in short interest in October. As of October 15th, there was short interest totalling 3,490,000 shares, a drop of 14.5% from the September 30th total of 4,080,000 shares. Based on an average daily volume of 588,600 shares, the days-to-cover ratio is currently 5.9 days.October 29, 2024 | marketbeat.comHarrow Unusual Options Activity For October 28October 28, 2024 | benzinga.comHarrow (NASDAQ:HROW) Trading Down 4.7% - Here's WhyHarrow (NASDAQ:HROW) Stock Price Down 4.7% - Here's What HappenedOctober 23, 2024 | marketbeat.comHarrow Health: Promising Growth Trajectory and Compelling Investment OpportunityOctober 17, 2024 | markets.businessinsider.com11,874 Shares in Harrow, Inc. (NASDAQ:HROW) Bought by SG Americas Securities LLCSG Americas Securities LLC acquired a new stake in Harrow, Inc. (NASDAQ:HROW - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 11,874 shares of the company's stock, valued at approximately $534,000.October 16, 2024 | marketbeat.comHarrow (NASDAQ:HROW) Reaches New 52-Week High - Still a Buy?Harrow (NASDAQ:HROW) Reaches New 1-Year High - What's Next?October 15, 2024 | marketbeat.comHarrow, Inc. (NASDAQ:HROW) Stock Holdings Lessened by Millennium Management LLCMillennium Management LLC trimmed its stake in Harrow, Inc. (NASDAQ:HROW - Free Report) by 13.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 138,137 shares of the company's stock after selling 20October 15, 2024 | marketbeat.comHarrow, Inc. (NASDAQ:HROW) Shares Bought by Creative PlanningCreative Planning lifted its holdings in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 96.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,486 shares of the company's stock after acquiring anOctober 14, 2024 | marketbeat.comI Am Banking On The Silver Tsunami With Big DividendsOctober 12, 2024 | seekingalpha.comCraig-Hallum Sticks to Its Buy Rating for Harrow Health (HROW)October 11, 2024 | markets.businessinsider.comOphir Asset Management's Strategic Reduction in Harrow Inc HoldingsOctober 8, 2024 | finance.yahoo.com53,249 Shares in Harrow, Inc. (NASDAQ:HROW) Bought by Marshall Wace LLPMarshall Wace LLP bought a new stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 53,249 shares of the company's stock, valued at approximately $October 7, 2024 | marketbeat.comLake Street Capital Boosts Harrow (NASDAQ:HROW) Price Target to $55.00Lake Street Capital upped their price objective on Harrow from $45.00 to $55.00 and gave the stock a "buy" rating in a report on Friday.October 4, 2024 | marketbeat.comLake Street Sticks to Their Buy Rating for Harrow Health (HROW)October 4, 2024 | markets.businessinsider.comCraig-Hallum Releases a Buy Rating on Harrow Health (HROW)October 4, 2024 | markets.businessinsider.comHarrow (NASDAQ:HROW) Sets New 1-Year High at $49.10Harrow (NASDAQ:HROW) Sets New 1-Year High at $49.10October 3, 2024 | marketbeat.comTraders Purchase High Volume of Harrow Put Options (NASDAQ:HROW)Harrow, Inc. (NASDAQ:HROW - Get Free Report) saw unusually large options trading on Thursday. Traders purchased 10,279 put options on the stock. This is an increase of approximately 955% compared to the average daily volume of 974 put options.October 3, 2024 | marketbeat.comHarrow Relaunches TRIESENCE®October 3, 2024 | finance.yahoo.comHarrow, Inc. (HROW): A Bull Case TheoryOctober 2, 2024 | msn.com Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Email Address “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in… >> YES! Send Me My FREE Gold Guide! HROW Media Mentions By Week HROW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HROW News Sentiment▼0.630.47▲Average Medical News Sentiment HROW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HROW Articles This Week▼153▲HROW Articles Average Week Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LifeVantage News Blueprint Medicines News Nuvalent News Corcept Therapeutics News Viking Therapeutics News Cytokinetics News TG Therapeutics News Ionis Pharmaceuticals News Crinetics Pharmaceuticals News Avidity Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HROW) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harrow, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harrow With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HROW Stock Alerts